Timonil 300 retard

Timonil 300 retard is a medicine authorised by Swissmedic under authorisation number 47127. The authorisation holder is Desitin Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 June 1986 and the authorisation is valid without a time limit. ATC code N03AF01 places the medicine in the group Antiepileptics.

  • Dispensing category B
  • Authorisation number 47127
  • ATC N03AF01
  • Synthetic medicines
Authorisation data
Authorisation number47127
NameTimonil 300 retard
Full nameTimonil 300 retard, Retardtabletten
Authorisation holderDesitin Pharma GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN03AF01
First authorisation19 June 1986
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Timonil 300 retard, RetardtablettenB19 June 1986
2Timonil 600 retard, RetardtablettenB19 June 1986
4Timonil 200 retard, RetardtablettenB26 March 2001
5Timonil 400 retard, RetardtablettenB26 March 2001

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
25100Tablette(n)N03AF0101.07.1.B
6850Tablette(n)N03AF0101.07.1.B
7650Tablette(n)N03AF0101.07.1.B
92200Tablette(n)N03AF0101.07.1.B
114100Tablette(n)N03AF0101.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Timonil 300 retard authorised in Switzerland?

Yes. Timonil 300 retard is authorised by Swissmedic under authorisation number 47127, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Timonil 300 retard have?

Timonil 300 retard is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Timonil 300 retard?

The authorisation holder is Desitin Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com